← Leaderboards
Kyung W Lee
Basic Sciences
$3,933,699
Attributed
$7,891,243
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.9M · FY2018–25$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,891,243 · 4
By mechanism
R01$7,891,243 · 4
Top collaborators
- John C He10 shared
- Mary E. Klotman4 shared
- Bhaskar Chandra Das2 shared
- Fang Zhong2 shared
Others in their field
Other Emerging Leaders on “Cells”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$155,695,588
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
- Evan Z Macosko · Broad Institute, Inc.$33,096,828
- James Dale Berry · Brigham And Women'S Hospital$30,122,905
- Hanjoon Ryu$28,519,898
- Eric C Palm · Florida State University$26,502,247
Research focus
CellsProteinsMediatingCell CyclePlayMalignant NeoplasmsEventMolecularBaseIn VitroPolo-Box DomainProtein KinaseCentrosomePhosphotransferasesPlk1 GeneDefectScaffoldMitoticStructureOverexpressionCentriolesSiteComplexTumorigenesis
Grant awards (77)
The role of Vpr-mediated cell cycle dysregulation in HIV-associated kidney disease$733,538
R01 · FY2025 · DK · contact PI
KLF2 is a novel endoprotective target for DKD$721,246
R01 · FY2025 · DK
Molecular basis of centriole duplication$693,209
ZIA · FY2025 · CA · contact PI
Impeding HIV-1-associated Non-Hodgkin's Lymphoma development by antagonizing Vpr$426,604
ZIA · FY2025 · CA · contact PI
Unraveling the molecular link between HIVAIDS and cancer$346,604
ZIA · FY2025 · CA · contact PI
Development of inhibitors targeting Plk1 polo-box domain$346,604
ZIA · FY2025 · CA · contact PI
Molecular basis of centriole duplication$1,055,155
ZIA · FY2024 · CA · contact PI
KLF2 is a novel endoprotective target for DKD$740,566
R01 · FY2024 · DK
The role of Vpr-mediated cell cycle dysregulation in HIV-associated kidney disease$710,734
R01 · FY2024 · DK · contact PI
Role of RARRES1 in diabetic kidney disease$429,081
R01 · FY2024 · DK · contact PI
Development of inhibitors targeting Plk1 polo-box domain$351,718
ZIA · FY2024 · CA · contact PI
Unraveling the molecular link between HIVAIDS and cancer$351,718
ZIA · FY2024 · CA · contact PI
Molecular basis of centriole duplication$1,105,026
ZIA · FY2023 · CA · contact PI
The role of Vpr-mediated cell cycle dysregulation in HIV-associated kidney disease$740,348
R01 · FY2023 · DK · contact PI
Unraveling the molecular link between HIVAIDS and cancer$518,342
ZIA · FY2023 · CA · contact PI
Role of RARRES1 in diabetic kidney disease$446,958
R01 · FY2023 · DK · contact PI
Development of inhibitors targeting Plk1 polo-box domain$368,342
ZIA · FY2023 · CA · contact PI
Molecular basis of centriole duplication$1,289,799
ZIA · FY2022 · CA · contact PI
The role of Vpr-mediated cell cycle dysregulation in HIV-associated kidney disease$779,195
R01 · FY2022 · DK · contact PI
Role of RARRES1 in diabetic kidney disease$446,958
R01 · FY2022 · DK · contact PI
The Role of LRG1 in Diabetic Kidney Disease$339,000
R01 · FY2022 · DK · contact PI
Development of inhibitors targeting Plk1 polo-box domain$276,385
ZIA · FY2022 · CA · contact PI
Unraveling the molecular link between HIVAIDS and cancer$276,385
ZIA · FY2022 · CA · contact PI
Molecular basis of centriole duplication$1,046,953
ZIA · FY2021 · CA · contact PI
Role of RARRES1 in diabetic kidney disease$447,619
R01 · FY2021 · DK · contact PI
The Role of LRG1 in Diabetic Kidney Disease$339,000
R01 · FY2021 · DK · contact PI
Unraveling the molecular link between HIVAIDS and cancer$224,347
ZIA · FY2021 · CA · contact PI
Development of inhibitors targeting Plk1 polo-box domain$224,347
ZIA · FY2021 · CA · contact PI
Molecular basis of centriole duplication$1,411,066
ZIA · FY2020 · CA · contact PI
Development of inhibitors targeting Plk1 polo-box domain$352,767
ZIA · FY2020 · CA · contact PI
The Role of LRG1 in Diabetic Kidney Disease$339,000
R01 · FY2020 · DK · contact PI
Molecular basis of centriole duplication$1,354,756
ZIA · FY2019 · CA · contact PI
The Role of LRG1 in Diabetic Kidney Disease$339,000
R01 · FY2019 · DK · contact PI
Development of inhibitors targeting Plk1 polo-box domain$338,689
ZIA · FY2019 · CA · contact PI
Molecular basis of centriole duplication$721,602
ZIA · FY2018 · CA · contact PI
Development of inhibitors targeting Plk1 polo-box domain$432,961
ZIA · FY2018 · CA · contact PI
The Role of LRG1 in Diabetic Kidney Disease$339,000
R01 · FY2018 · DK · contact PI
Polo-like kinase 1 (Plk1)-dependent centrosome maturation and spindle bipolarity$288,640
ZIA · FY2018 · CA · contact PI
Molecular basis of centriole duplication$714,627
ZIA · FY2017 · CA · contact PI
Development of inhibitors targeting Plk1 polo-box domain$428,776
ZIA · FY2017 · CA · contact PI
Polo-like kinase 1 (Plk1)-dependent centrosome maturation and spindle bipolarity$285,850
ZIA · FY2017 · CA · contact PI
Molecular basis of centriole duplication$485,887
ZIA · FY2016 · CA · contact PI
Development of inhibitors targeting Plk1 polo-box domain$364,417
ZIA · FY2016 · CA · contact PI
Polo-like kinase 1 (Plk1)-dependent centrosome maturation and spindle bipolarity$364,417
ZIA · FY2016 · CA · contact PI
Molecular basis of centriole duplication$474,847
ZIA · FY2015 · CA · contact PI
Polo-like kinase 1 (Plk1)-dependent centrosome maturation and spindle bipolarity$356,135
ZIA · FY2015 · CA · contact PI
Development of inhibitors targeting Plk1 polo-box domain$356,135
ZIA · FY2015 · CA · contact PI
Molecular basis of centriole duplication$474,560
ZIA · FY2014 · CA · contact PI
Polo-like kinase 1 (Plk1)-dependent centrosome maturation and spindle bipolarity$355,920
ZIA · FY2014 · CA · contact PI
Development of inhibitors targeting Plk1 polo-box domain$355,920
ZIA · FY2014 · CA · contact PI
Centrosomal proteins in the regulation of spindle bipolarity and ciliogenesis$433,124
ZIA · FY2013 · CA · contact PI
Development of anti-polo-box therapeutic agents$324,842
ZIA · FY2013 · CA · contact PI
Molecular basis of centriole duplication$324,842
ZIA · FY2013 · CA · contact PI
Centrosomal proteins in the regulation of spindle bipolarity and ciliogenesis$442,432
ZIA · FY2012 · CA · contact PI
Characterization of the hCenexin-Plk1 interaction at the centrosomes$331,824
ZIA · FY2012 · CA · contact PI
Development of anti-polo-box therapeutic agents$331,824
ZIA · FY2012 · CA · contact PI
Centrosomal proteins in the regulation of spindle bipolarity and ciliogenesis$446,925
ZIA · FY2011 · CA · contact PI
Development of anti-polo-box therapeutic agents$335,193
ZIA · FY2011 · CA · contact PI
Characterization of the hCenexin-Plk1 interaction at the centrosomes$335,193
ZIA · FY2011 · CA · contact PI
Characterization of PBIP1, a novel polo-box-binding protein at the kinetochores$342,777
ZIA · FY2010 · CA · contact PI
Development of anti-polo-box therapeutic agents$342,777
ZIA · FY2010 · CA · contact PI
Characterization of the hCenexin-Plk1 interaction at the centrosomes$228,518
ZIA · FY2010 · CA · contact PI
Centrosomal proteins in the regulation of spindle bipolarity and ciliogenesis$228,518
ZIA · FY2010 · CA · contact PI
Characterization of the hCenexin-Plk1 interaction at the centrosomes$394,463
ZIA · FY2009 · CA · contact PI
Characterization of PBIP1, a novel polo-box-binding protein at the kinetochores$394,463
ZIA · FY2009 · CA · contact PI
Development of anti-polo-box therapeutic agents$338,112
ZIA · FY2009 · CA · contact PI
Characterization of PBIP1, a novel polo-box-binding protein at the kinetochores$310,192
Z01 · FY2008 · CA · contact PI
Characterization of PBIP1, a novel polo-box-interacting protein at the kinetocho$200,268
Z01 · FY2007 · CA · contact PI
Regulation of G2M transition in budding yeast$0
Z01 · FY2006 · BC · contact PI
Characterization of PBIP1, a novel polo-box-interacting$0
Z01 · FY2006 · BC · contact PI
Regulation of G2M transition in budding yeast$0
Z01 · FY2005 · BC
Characterization of PBIP1, a novel polo-box-interacting$0
Z01 · FY2005 · BC
Regulation of G2/M transition$0
Z01 · FY2004 · BC
Characterization of the polo-box binding proteins in bud$0
Z01 · FY2004 · BC
Regulation of G2/M transition$0
Z01 · FY2003 · BC
Isolation and characterization of novel anti-mitotic age$0
Z01 · FY2003 · BC
Polo-box binding proteins in budding yeast and mammalian$0
Z01 · FY2003 · BC